Psyence (PSYG) is a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well‑being. We have a focus on these conditions in the context of palliative care.
Psyence is listed on the Canadian Stock Exchange (CSE: PSYG) and on the US OTCQB® Venture Market (OTCQB: PSYGF). Our diversified business has a global footprint with operations in multiple legal jurisdictions. We operate one of the first federally licensed commercial psilocybin cultivation and production facilities in the world in Southern Africa.
For more information: www.psyence.com
Company Details
- Employees
- 11
- Founded
- 2019
- Address
- 200 Bay Street, Suite 210,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.psyence.com/
- HQ
- Toronto, Ontario
Psyence Group Questions
Psyence Group's website is https://www.psyence.com/
Psyence Group's LinkedIn profile is https://ca.linkedin.com/company/the-psyence-group
Psyence Group has
11 employees.
View email and phone details for 11
employees at Psyence Group.
Psyence Group's industry is
Biotechnology Research
Psyence Group's top competitors are
Usona Institute,
Psyence Biomedical Ltd,
Psylabs,
Lykos Therapeutics,
Tactogen,
Tryp Therapeutics,
Opterion Health Ag,
Gh Research Plc,
Cybin Inc,
Compass Pathways.
Psyence Group's categories are Biotechnology Research
Psyence Group's founding year is 2019
